Title : Enhancement of Gene Knockdown on CD22-Expressing Cells by Chemically Modified Glycan Ligand-siRNA Conjugates.

Pub. Date : 2022 Feb 18

PMID : 35020348






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 To target CD22-expressing B cells, several drug platforms have shown promise, including antibodies, antibody-drug conjugates, and nanoparticles, but to date CD22-targeted delivery of oligonucleotide therapeutics has not been reported. Oligonucleotides CD22 molecule Homo sapiens
2 To target CD22-expressing B cells, several drug platforms have shown promise, including antibodies, antibody-drug conjugates, and nanoparticles, but to date CD22-targeted delivery of oligonucleotide therapeutics has not been reported. Oligonucleotides CD22 molecule Homo sapiens